Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Epizyme + 20 Stocks Moving In Monday’s Pre-Market Session
Gainers
Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
Recap: Reed’s Q1 Earnings
Reed's (NASDAQ:REED) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Reed's missed estimated earnings by 25.0%, reporting an EPS of $-0.05 versus an estimate of $-0.04.
Reed’s Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $12.20M Miss $13.10M Estimate
Reed's (NASDAQ:REED) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is unchanged from the same period last year. The company reported quarterly
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
55 Biggest Movers From Friday
Gainers
Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday.
38 Stocks Moving In Friday’s Mid-Day Session
Gainers
Manning & Napier, Inc. (NYSE: MN) jumped 40.7% to $12.82 after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share.
Reed Stock Slides After Hours As Q4 Results Miss Expectations
Reed’s, Inc. (NASDAQ:REED) reported fourth-quarter revenue growth of 20% year-over-year to $12.8 million, missing the consensus of $13.02 million. The…